Elizabeth Glaser Pediatric AIDS Foundation
1120 19th St NW Ste 500, Washington, DC · IRS data through FY2024
Revenue, expenses and net assets
Revenue Expenses Net assets
| Tax year | Revenue | Expenses | Net assets |
|---|---|---|---|
| FY2024 | $138,028,470 | $140,023,453 | $8,610,030 |
| FY2023 | $162,295,489 | $162,458,737 | $9,433,344 |
| FY2022 | $172,481,008 | $172,087,793 | $8,938,659 |
| FY2021 | $187,687,168 | $185,043,941 | $10,100,445 |
| FY2020 | $165,216,570 | $168,062,128 | $7,255,301 |
| FY2019 | $202,227,730 | $201,028,105 | $9,821,441 |
| FY2018 | $199,909,040 | $199,862,241 | $8,209,064 |
| FY2017 | $180,487,409 | $180,014,269 | $8,449,826 |
| FY2016 | $143,494,416 | $142,583,831 | $7,707,695 |
| FY2015 | $120,699,012 | $120,658,812 | $6,674,059 |
| FY2014 | $126,056,619 | $126,187,776 | $6,724,023 |
| FY2013 | $119,164,859 | $121,432,406 | $7,471,883 |
| FY2012 | $121,579,564 | $123,634,170 | $9,545,158 |
| FY2011 | $161,703,471 | $164,151,044 | $11,583,246 |
Form 990 filings
The returns filed by Elizabeth Glaser Pediatric AIDS Foundation (EIN 95-4191698), including Form 990 PDFs and e-file data by year, are available in ProPublica's Nonprofit Explorer. The figures on this page come from IRS data files built from those returns.
Where the revenue came from
| Source | Amount | % of revenue |
|---|---|---|
| Contributions & grants | $137,741,552 | 100% |
| Program service revenue | $0 | 0% |
Where the money was spent
| Category | Amount | % of expenses |
|---|---|---|
| Program services | $123,480,798 | 88% |
| Management & general | $12,682,491 | 9% |
| Fundraising | $3,860,164 | 3% |
What the numbers show
- Contributions & grants made up 100% of total revenue in FY2024.
- Program services accounted for 88% of functional expenses, management & general 9%, and fundraising 3%.
- 88% of functional expenses went to program services in FY2024. That is higher than 69.4% of 157 Medical Research organizations nationwide (too few in DC for a state comparison).
- Net assets covered about 0.7 months of expenses at the end of the reporting year. That puts it in the 8th percentile among 36 Medical Research organizations in DC.
- Total revenue was the highest among 36 Medical Research organizations in DC.
- Total revenue fell from $161,703,471 in FY2011 to $138,028,470 in FY2024. Revenue increased in 6 and decreased in 7 of 13 year-over-year comparisons.
- Expenses exceeded revenue in 7 of 14 reported years (FY2011, FY2012, FY2013, FY2014, FY2020, FY2023, FY2024).
- The highest revenue on record here is $202,227,730 in FY2019.
- Net assets declined from $11,583,246 to $8,610,030 between FY2011 and FY2024.
- Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity).
Figures compared against other organizations of the same NTEE program area in the same state. See the methodology page for how these are calculated and the guide to reading nonprofit financials for their limits.
About this organization
THE ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION SEEKS TO END HIV/AIDS GLOBALLY IN CHILDREN, YOUTH, AND FAMILIES.
IRS status
| Ruling year | 1989 |
| Subsection | 501(c)(3) |
| Classification | Public charity |
| Program area (NTEE) | H810 — Medical Research |
| Donations | Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity). |
Similar organizations
- Childrens Research Institute — Washington, DC · $109,384,265
- Paralyzed Veterans of America — Washington, DC · $83,222,092
- Society for Neuroscience — Washington, DC · $36,716,820
Source: Internal Revenue Service — Exempt Organizations Business Master File (downloaded November 4, 2026), Statistics of Income extracts, Form 990 e-file data, Publication 78 and the Automatic Revocation list. Figures are as reported by the organization; IRS processing may adjust them. This is not a charity rating and not tax advice. Confirm deductibility in IRS Tax Exempt Organization Search.
Think something here is wrong or should be removed? Use the contact form — we act on removal requests within 30 days.